The drugmaker will pay $10 million in the case, plus additional contributions worth $10.4 million, to avoid going to trial in two Ohio counties for its role in the opioids crisis.
Published: October 2, 2019 at 03:26AM
from NYT Health https://ift.tt/2nrLBm9